Award | April 26, 2024
Press & Publications
Press
Press Release | March 22, 2024
SYNLAB et ALCEDIAG lancent en France le test sanguin myEDIT-B pour différencier la dépression et les troubles bipolaires.
Press Release | December 07, 2023
ALCEDIAG receives BPI France grant for EDIT-B® blood test clinical utility study
Press Release | November 06, 2023
50% Recruitment milestone reached in clinical validation study of EDIT B blood test: An aid for differential diagnosis of bipolar disorder based on RNA Editing biomarkers
Award | October 09, 2023
Finalist list of the European Lifestars Awards – Celebrating Life Science eXecutives & their partners!
Award | March 28, 2023
We won the Medical Diagnostic trophy at the 2nd edition of the “Healthtech awards” organised by France Biotech!
Press Release | March 27, 2023
ALCEDIAG and SYNLAB join forces in Europe to fight diagnostic delay of bipolar disorder with the EDIT-B™ test
News | November 18, 2022
OUEST-FRANCE À Montpellier, une start-up développe un test pour diagnostiquer la bipolarité
News | July 12, 2022
ALCEDIAG Announces the Inclusion of the First Patient in clinical validation study for EDIT-B test: an aid for differential diagnosis of bipolar disorder, based on RNA editing blood biomarkers
Scientific Publications
International Journal of Molecular Sciences | December 03, 2024
RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar, and Schizoaffective Disorders
Francisco J. Checa-Robles, Nicolas Salvetat, Christopher Cayzac, Mary Menhem, Mathieu Favier, Diana Vetter, Ilhème Ouna, João V. Nani, Mirian A. F. Hayashi, Elisa Brietzke, Dinah Weissmann
Journal of Affective Disorder | April 22, 2024
AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort
Nicolas Salvetat, Francisco Jesus Checa-Robles, Aurélie Delacrétaz, Christopher Cayzac, Benjamin Dubuc, Diana Vetter, Jacques Dainat, Jean-Philippe Lang, Franziska Gamma, Dinah Weissmann
Psychiatry Research | September 10, 2023
Euthymic and depressed bipolar patients are characterized by different RNA editing patterns in blood
Mirian A.F. Hayashi, Nicolas Salvetat, Christopher Cayzac, Francisco Jesus Checa-Robles, Benjamin Dubuc, Sandie Mereuze, João V. Nani, Franck Molina, Elisa Brietzke, Dinah Weissmann
Translational Psychiatry | July 06, 2022
A game changer for bipolar disorder diagnosis using RNA editing-based biomarkers
Nicolas Salvetat, Francisco Jesus Checa-Robles, Vipul Patel, Christopher Cayzac, Benjamin Dubuc, Fabrice Chimienti, Jean-Daniel Abraham, Pierrick Dupré, Diana Vetter, Sandie Méreuze, Jean-Philippe Lang, David J. Kupfer, Philippe Courtet, Dinah Weissmann
Translational Psychiatry | March 05, 2021
Phosphodiesterase 8A to discriminate in blood samples depressed patients and suicide attempters from healthy controls based on A-to-I RNA editing modifications
Nicolas Salvetat, Fabrice Chimienti, Christopher Cayzac, Benjamin Dubuc, Francisco Checa-Robles, Pierrick Dupre, Sandie Mereuze, Vipul Patel, Catherine Genty, Jean-Philippe Lang, Jean-François Pujol, Philippe Courtet & Dinah Weissmann
Journal of NeuroVirology | October 21, 2019
RNA editing blood biomarkers for predicting mood alterations in HCV patients
N. Salvetat, S. Van der Laan, B. Vire, F. Chimienti, S. Cleophax, J. P. Bronowicki, M. Doffoel, M. Bourlière, R. Schwan, J. P. Lang, J. F. Pujol, D. Weissmann
Translational Psychiatry | February 15, 2019
Brain region-specific alterations of RNA editing in PDE8A mRNA in suicide decedents
Fabrice Chimienti, Laurent Cavarec, Laurent Vincent, Nicolas Salvetat, Victoria Arango, Mark D. Underwood, J. John Mann, Jean-François Pujol, Dinah Weissmann
Drug Discovery Today | April 14, 2017
Emerging RNA editing biomarkers will foster drug development
S. Van der Laan, S. Salvetat, D. Weissmann, F. Molina
Translational Psychiatry | August 30, 2016
Region-specific alterations of A-to-I RNA editing of serotonin 2c receptor in the cortex of suicides with major depression
D Weissmann, S van der Laan, MD Underwood, N Salvetat, L Cavarec, L Vincent, F Molina, JJ Mann, V Arango and JF Pujol
Translational Psychiatry | August 20, 2016
In vitro screening for drug-induced depression and/or suicidal adverse effects: a new toxicogenomic assay based on CE-SSCP analysis of HTR2C mRNA editing in SH-SY5Y cells
D Weissmann, S van der Laan, MD Underwood, N Salvetat, L Cavarec, L Vincent, F Molina, JJ Mann, V Arango and JF Pujol